Propafenone-induced acute generalized exanthematous pustulosis [1]

International Journal of Dermatology

Volumn 44, Issue 3, 2005, Pages 256-257

  Huang, Yi Ming ^a   Lee, Woan Ruoh ^a   Hu, Chung Hong ^a   Cheng, Kuo Liang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; DIGOXIN; HYDROCORTISONE; PROCATEROL; PROPAFENONE; SALMETEROL;

ACUTE DISEASE; AGED; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DIZZINESS; DRUG ERUPTION; DRUG WITHDRAWAL; ERYTHEMA; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; MALE; NOTE; PAPULE; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PUSTULOSIS; RECURRENT DISEASE; SKIN BIOPSY; SKIN EXFOLIATION; TASTE DISORDER; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; DRUG ERUPTIONS; EXANTHEMA; HUMANS; MALE; PROPAFENONE; SKIN DISEASES, PAPULOSQUAMOUS;

EID: 15844390289     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02311.x     Document Type: Note

References (4)

1. Brentano CF, Kroemer HK, Lee JT, et al. Drug therapy. Propafenone N Engl J Med 1990; 332: 518-525.
2. Sidoroff A, Halevy S, Bavinck JNB, et al. Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 2001; 28: 113-119.
3. Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107: 1433-1441.
4. Guindo J, Serna AR, Borja J, et al. Propafenone and a syndrome of the lupus erythematosus type. Ann Int Med 1986; 104 589.